SCHEMBL30120002

SCHEMBL30120002

CC(CCn1cnc2ccc(O)cc2c1=O)C1CCN(C(=O)OC(C)(C)C)CC1

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 10/20 0.42
HCAR1 Q9BXC0 1/20 0.41
MCL1 Q07820 1/20 0.39
PIK3CD O00329 2/20 0.39
PIK3CA P42336 2/20 0.39
PIK3CB P42338 2/20 0.39
PIK3CG P48736 2/20 0.39
DPP4 P27487 1/20 0.38
USP7 Q93009 1/20 0.38
SYK P43405 1/20 0.38
POLB P06746 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
TNF P01375 1/20 0.38
PDE4A P27815 1/20 0.38
PDE4B Q07343 1/20 0.38
PDE4C Q08493 1/20 0.38
PDE4D Q08499 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24752971 1.00 GPR119 (0.42) GPR119HCAR1MCL1PIK3CDPIK3CA
SCHEMBL24542863 0.86 ACHE (0.46) GPR119HCAR1USP7
SCHEMBL31548396 0.83 USP7 (0.50) GPR119HCAR1PIK3CDPIK3CAPIK3CB
SCHEMBL30120142 0.82 HCAR1 (0.41) GPR119HCAR1MCL1PIK3CDPIK3CA
SCHEMBL24752951 0.82 HCAR1 (0.41) GPR119HCAR1MCL1PIK3CDPIK3CA
SCHEMBL24542757 0.82 IDO1 (0.44) HCAR1POLBSMN1; SMN2TNF
SCHEMBL24542759 0.81 BACE1 (0.45) HCAR1PIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL30120107 0.81 BRAF (0.45) GPR119DPP4
SCHEMBL24752970 0.81 BRAF (0.45) GPR119DPP4
SCHEMBL24753270 0.80 HCAR1 (0.41) GPR119HCAR1PIK3CDPIK3CAPIK3CB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4351583-A1 THERAPEUTICS FOR THE DEGRADATION OF MUTANT BRAF C4 Therapeutics, Inc. (US) 2024-04-17 EP disclosed
WO-2022261250-A1 THERAPEUTICS FOR THE DEGRADATION OF MUTANT BRAF C4 THERAPEUTICS, INC. (US) 2022-12-15 WO disclosed